Friday, July 31, 2026

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

Fighter Jets, Drones, and Refueling Missions: Inside the Massive U.S.-South Korea Air Exercise

South Korea and U.S. Air Forces conduct 'Freedom Flag' exercise, enhancing joint operations with air refueling and UAV integrations.

Tag: control

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Meta’s New Wristband Reads Your Mind—Before You Move a Muscle

Meta has launched an AI-powered wristband that enables gesture control of devices, showcasing a breakthrough in non-invasive technology.

KAIST Unveils Next-Gen Smart Window That Slashes Indoor Heat by 49°F

KAIST's Professor Moon Hong Cheol unveils RECM, a smart window tech that adjusts light and heat, enhancing comfort and reducing glare.

Hyundai Just Built a Car That Speeds Up to Dodge Tailgaters

Hyundai Mobis introduces a safety tech that autonomously accelerates vehicles to prevent rear-end collisions on highways.

South Korean Scientists Build First Chip That Sees ‘Twisted’ Light

KAIST's research team developed the world's first semiconductor material for detecting circularly polarized light using selenium nanocrystals.

Muscle Loss May Start in the Brain, Not the Body, Researchers Say

A study reveals that age-related muscle loss may originate from brain dysfunction, suggesting new therapies targeting the dopamine system.

Lexus LX700h: First-Class Comfort Meets Unstoppable Off-Road Performance

The Lexus LX700h excels in off-road performance and luxury, featuring advanced technology for various terrains and a smooth on-road ride.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Could You Have Diabetes? Here’s What You Should Know About the Rising Numbers

In 2022, 14.8% of adults over 30 had diabetes; effective management remains a challenge despite rising awareness and lifestyle changes.

South Korea Downplays Impact of U.S. Tech Restrictions: Here’s Why It Might Not Matter

South Korea views new US export controls on advanced tech as minimally impactful, with potential for future exceptions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.